Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

Abstract Chimeric antigen receptor natural killer cells (CAR-NK) promote off-the-shelf cellular therapy for solid tumors and malignancy.However,, the development of CAR-NK is due to their immune surveillance uncertainty and cytotoxicity challenge was restricted. Natural killer cell-derived exosome (...

Full description

Bibliographic Details
Main Authors:	Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary, Ala Amiri, Vahid Karpisheh, Kaveh Nasrollahi, Reza Jafari
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Series:	Cancer Cell International
Subjects:	Natural killer cell Exosomes NK-derived Exosomes CAR-NK Cancer immunotherapy Fas/FasL pathway
Online Access:	https://doi.org/10.1186/s12935-023-02996-6

Similar Items

Ovarian cancer treatment and natural killer cell-based immunotherapy
by: Zhongru Fan, et al.
Published: (2023-12-01)

Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway
by: Xiao-Li Li, et al.
Published: (2016-01-01)

The role of apoptosis in pathogenesis of type 1 diabetes mellitus
by: Elena Vladimirovna Pekareva, et al.
Published: (2010-03-01)

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
by: Lydia Navarrete-Galvan, et al.
Published: (2022-04-01)

Leucemia mielóide crônica e o sistema Fas-FasL Chronic myeloid leukemia and the Fas-FasL system
by: Ana Paula F. Bergantini, et al.
Published: (2005-06-01)

Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer
by: Jolanta Czyżewska, et al.
Published: (2011-04-01)

Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women
by: Wang M, et al.
Published: (2016-07-01)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
by: Siyao Liu, et al.
Published: (2022-12-01)

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders
by: Fusun Gediz Ozdemirkiran, et al.
Published: (2016-05-01)

Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation
by: Anthony J. Leonardi, et al.
Published: (2022-03-01)

CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
by: Matthieu Le Gallo, et al.
Published: (2017-09-01)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
by: Ikomey George M, et al.
Published: (2012-06-01)

CART cells are prone to Fas- and DR5-mediated cell death
by: Benjamin O. Tschumi, et al.
Published: (2018-07-01)

Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response
by: Zuzana Strizova, et al.
Published: (2021-04-01)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome
by: Elisa Brandetti, et al.
Published: (2021-08-01)

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma
by: Fangfang Ge, et al.
Published: (2023-08-01)

Immunohistochemical Analysis of the Extrinsic Apoptosis Process in the Non-Neoplastic and Neoplastic Prostate
by: Ayşe Burcu İLERİ, et al.
Published: (2018-01-01)

Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
by: A. Berdeli, et al.
Published: (2012-12-01)

Examination of Fas-Induced Apoptosis of Murine Thymocytes in Thymic Tissue Slices Reveals That Fas Is Dispensable for Negative Selection
by: Chang-Feng Chu, et al.
Published: (2020-10-01)

Expression of FasL in Proliferation of Retinoblastoma Cells: A Mechanism Fas Counterattack
by: Hendrian Dwikoloso Soebagjo, et al.
Published: (2014-08-01)

Adenovirus-Mediated <i>FasL</i> Minigene Transfer Endows Transduced Cells with Killer Potential
by: Madalina Dumitrescu, et al.
Published: (2020-08-01)

Natural killer cells: a promising immunotherapy for cancer
by: Junfeng Chu, et al.
Published: (2022-05-01)

The application of natural killer (NK) cell immunotherapy for the treatment of cancer
by: Rayne H Rouce, et al.
Published: (2015-11-01)

Plasma Levels of sFas-sFasL and <i>FASL</i> Gene Expression Are Associated with Tuberculosis
by: Iury de Paula Souza, et al.
Published: (2022-12-01)

E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL
by: Noor Mustafa, et al.
Published: (2021-12-01)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
by: Adela Kratochvilova, et al.
Published: (2021-08-01)

Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death
by: Joseph H Su, et al.
Published: (2003-04-01)

Non-apoptotic Fas (CD95) Signaling on T Cells Regulates the Resolution of Th2-Mediated Inflammation
by: Jesse W. Williams, et al.
Published: (2018-11-01)

The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
by: Kellsye P. Fabian, et al.
Published: (2021-12-01)

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
by: Kari A. Shaver, et al.
Published: (2021-04-01)

Immunological Role of Megakaryocytes and Platelets during Influenza A Virus Infection
by: Fryad M. Rahman
Published: (2023-08-01)

Evaluation of the FAS and FASL Gene changes in women with premature ovarian failure: A case-control study
by: Zhima Akhavansales, et al.
Published: (2022-12-01)

Species difference in the expression of Fas and Fas ligand in mature mammalian spermatozoa
by: Youwei Li, et al.
Published: (2017-12-01)

<i>Naja atra</i> Cardiotoxin 1 Induces the FasL/Fas Death Pathway in Human Leukemia Cells
by: Jing-Ting Chiou, et al.
Published: (2021-08-01)

Mild hypothermia reduces expression of Fas/FasL and MMP-3 after cerebral ischemia-reperfusion in rats
by: Jingkun Zhao, et al.
Published: (2014-06-01)

Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
by: Giovanna Flores-Mendoza, et al.
Published: (2021-03-01)

Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
by: Malgorzata Krzyzowska, et al.
Published: (2021-08-01)

Natural killer cells: the next wave in cancer immunotherapy
by: Xin Chen, et al.
Published: (2022-07-01)

The prospect of genetically engineering natural killer cells for cancer immunotherapy
by: Angie Yu Ching Poon, et al.
Published: (2022-12-01)

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
by: Zhipu Niu, et al.
Published: (2024-04-01)